Inventor
DE JONGE MARC RENE
NL25 patents
⚠️ This page may combine multiple inventors who share the name “DE JONGE MARC RENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
16 patentsUS7514445B2Apr 7, 2009
Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)
JANSSEN PHARMACEUTICA NV117 citations97
US7125879B2Oct 24, 2006
HIV inhibiting pyrimidines derivatives
JANSSEN PHARMACEUTICA NV96 citations97
US6150360ANov 21, 2000
Trisubstituted 1,3,5-Triazine Derivatives
JANSSEN PHARMACEUTICA NV62 citations96
US6440986B2Aug 27, 2002
HIV Inhibiting pyrimidine derivatives
JANSSEN PHARMACEUTICA NV74 citations95
US7923554B2Apr 12, 2011
HIV inhibiting 1,2,4-triazin-6-one derivatives
JANSSEN PHARMACEUTICA NV26 citations91
US7034019B2Apr 25, 2006
Prodrugs of HIV replication inhibiting pyrimidines
JANSSEN PHARMACEUTICA NV14 citations83
US6774235B2Aug 10, 2004
Trisubstituted 1,3,5-triazine derivatives
JANSSEN PHARMACEUTICA NV7 citations73
US6372729B1Apr 16, 2002
Trisubstituted 1,3,5,-triazine derivatives
JANSSEN PHARMACEUTICA NV5 citations73
US8026248B2Sep 27, 2011
HIV inhibiting pyrimidine derivatives
JANSSEN PHARMACEUTICA NV4 citations62
US6638932B1Oct 28, 2003
2,4-disubstituted triazine derivatives
JANSSEN PHARMACEUTICA NV2 citations62
US7763631B2Jul 27, 2010
Prodrugs of HIV replication inhibiting pyrimidines
JANSSEN PHARMACEUTICA NV2 citations61
US7015221B2Mar 21, 2006
2,4-disubstituted triazine derivatives
JANSSEN PHARMACEUTICA NV0 citations52
US8378085B2Feb 19, 2013
Bacterial ATP synthase binding domain
JANSSEN PHARMACEUTICA NV0 citations46
US8026245B2Sep 27, 2011
HIV replication inhibiting purine derivatives
JANSSEN PHARMACEUTICA NV0 citations39
US7105522B2Sep 12, 2006
HIV inhibiting pyrazinone derivatives
JANSSEN PHARMACEUTICA NV0 citations39
US7585861B2Sep 8, 2009
HIV inhibiting 1,2,4-triazines
JANSSEN PHARMACEUTICA NV0 citations38